Birkenstock Holding PLC (NYSE:BIRK) Stock Has Consensus Target Price of $52.50 According to Brokerages

Birkenstock Holding PLC (NYSE:BIRK) has been assigned a consensus recommendation of “Moderate Buy” from the nineteen research firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and thirteen have given a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $51.91.

BIRK has been the subject of several research analyst reports. Seaport Research Partners downgraded shares of Birkenstock from a “buy” rating to a “neutral” rating in a report on Monday, July 20th. Weiss Ratings cut shares of Birkenstock from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, September 22nd. Williams Trading cut shares of Birkenstock from a “hold” rating to a “strong sell” rating in a report on Friday. BMO Capital Markets initiated coverage on shares of Birkenstock in a research report on Tuesday, September 8th. They set a “market perform” rating and a $35.00 price objective for the company. Finally, BTIG Research restated a “buy” rating and set a $60.00 price objective on shares of Birkenstock in a research report on Friday, August 14th.

Hedge Funds Weigh In On Birkenstock

Institutional investors and hedge funds have recently made changes to their positions in the company. Vontobel Holding Ltd. bought a new position in Birkenstock during the 3rd quarter worth $905,000. Mather Group LLC. acquired a new stake in shares of Birkenstock during the third quarter worth $27,000. WINTON GROUP Ltd acquired a new stake in shares of Birkenstock during the second quarter worth $417,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Birkenstock during the second quarter worth $34,000. Finally, Squarepoint Ops LLC boosted its position in shares of Birkenstock by 438.0% in the second quarter. Squarepoint Ops LLC now owns 99,537 shares of the company’s stock valued at $4,283,000 after acquiring an additional 81,037 shares during the period. Institutional investors and hedge funds own 19.93% of the company’s stock.

Birkenstock Trading Up 0.1%

BIRK stock opened at $33.88 on Friday. Birkenstock has a one year low of $29.93 and a one year high of $50.73. The stock has a market cap of $6.03 billion, a price-to-earnings ratio of 15.87, a price-to-earnings-growth ratio of 1.12 and a beta of 1.30. The company has a fifty day moving average price of $34.03 and a two-hundred day moving average price of $38.56. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.78 and a quick ratio of 2.09.

Birkenstock (NYSE:BIRK) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.86 earnings per share for the quarter, missing the consensus estimate of $0.88 by ($0.02). The company had revenue of $834.65 million during the quarter, compared to the consensus estimate of $827.39 million. Birkenstock had a net margin of 14.82% and a return on equity of 13.36%. Birkenstock’s revenue for the quarter was up 13.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.62 earnings per share. Birkenstock has set its FY 2026 guidance at 2.220-2.400 EPS. Equities analysts anticipate that Birkenstock will post 2.19 EPS for the current year.

Birkenstock Company Profile

Birkenstock is a global footwear company best known for its contoured cork-latex footbed, which is designed to support the natural shape of the foot. The company offers sandals, shoes, clogs, boots and other footwear, along with accessories and foot-care products. Its portfolio includes classic styles such as Arizona, Boston, Madrid and Gizeh.

Birkenstock traces its roots to 1774, when Johann Adam Birkenstock was recorded as a shoemaker in Germany. The company’s modern footbed concept was developed in the late 19th and early 20th centuries, helping establish its reputation for comfort, functionality and orthopedic-inspired design.